L. Bruni, G. Albero, M. Aldea, B. Serrano, S. Valencia et al., ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World, pp.12-20, 2014.

Z. El-khatib, J. E. Tota, and A. M. Kaufmann, Progress on human papillomavirus (HPV) infection and cervical cancer prevention in sub-Saharan Africa: highlights of the 27th International Papillomavirus Conference in Berlin, J Epidemiol Global Health, vol.2, issue.2, pp.99-102, 2011.

M. Arbyn, X. Castellsague, S. De-sanjose, L. Bruni, M. Saraiya et al., Worldwide burden of cervical cancer in 2008, Ann Oncol, vol.22, issue.12, pp.2675-86, 2011.

P. O. Adefuye, O. A. Dada, B. O. Adefuye, T. O. Shorunmu, and B. O. Akinyemi, IdowuAjiboye BO. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria

, Int J Gynaecol Obstet, vol.129, issue.1, pp.62-68, 2015.

M. Urasa and E. Darj, Knowledge of cervical cancer and screening practices of nurses at a regional hospital in Tanzania, Afr Health Sci, vol.11, issue.1, pp.48-57, 2011.

H. Vedantham, M. I. Silver, B. Kalpana, C. Rekha, B. P. Karuna et al., Determinants of VIA (Visual Inspection of the Cervix After Acetic Acid Application) positivity in cervical cancer screening of women in a periurban area in Andhra Pradesh, India. Cancer Epidemiol Biomark Prev, vol.19, issue.5, pp.1373-80, 2010.

J. M. Walboomers, M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, issue.1, pp.12-21, 1999.

S. De-sanjose, W. G. Quint, L. Alemany, D. T. Geraets, J. E. Klaustermeier et al., Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study, Lancet Oncol, vol.11, issue.11, pp.70230-70238, 2010.

A. C. Mcdonald, L. Denny, C. Wang, W. Y. Tsai, W. Jr et al., Distribution of high-risk human papillomavirus genotypes among HIV-negative women with and without cervical intraepithelial neoplasia in South Africa, PLoS One, vol.7, issue.9, p.44332, 2012.

. Globocan, Cancer Fact sheets, 2012.

A. Si-mohamed, A. Ndjoyi-mbiguino, K. Cuschieri, I. N. Onas, I. Colombet et al., High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, Gabon, J Med Virol, vol.77, issue.3, pp.430-438, 2005.

S. Assoumou, L. M. Mbiguino, A. N. Mabika, B. M. Belembaogo, E. Khattabi et al., Sequence variations of human papillomavirus type 16 E6 and E7 genes in cervical cancer isolates from Gabon, Br Microbiol Res J, vol.8, issue.2, pp.386-94, 2015.

, WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention, 2013.

R. Sankaranarayanan, R. Wesley, S. Thara, N. Dhakad, B. Chandralekha et al., Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India, Int J Cancer, vol.106, issue.3, pp.404-412, 2003.

T. Yamada, C. M. Wheeler, A. L. Halpern, A. C. Stewart, A. Hildesheim et al., Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments, J Virol, vol.69, issue.12, pp.7743-53, 1995.

A. Huertas-salgado, D. C. Martin-gamez, P. Moreno, R. Murillo, M. M. Bravo et al., E6 molecular variants of human papillomavirus (HPV) type 16: an updated and unified criterion for clustering and nomenclature, Virology, vol.410, issue.1, pp.201-216, 2011.

W. H. Organization, WHO Guidelines for screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention, 2013.

C. Mahe and L. Gaffikin, Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening, Cancer Causes Control, vol.16, issue.6, pp.657-66, 2005.

P. Basu, S. Mittal, D. Banerjee, P. Singh, C. Panda et al., Diagnostic accuracy of VIA and HPV detection as primary and sequential screening tests in a cervical cancer screening demonstration project in India, Int J Cancer, vol.137, issue.4, pp.859-67, 2015.

E. Mpiga, M. Ivanga, I. H. Koumakpayi, C. Engohan-aloghe, J. C. Ankely et al., Interest in visual inspection with acetic acid and Lugol iodine with colposcope in screening of cervical lesions in Gabon, Pan Afr Med J, vol.22, p.165, 2015.

Z. Assoumou, S. , N. Mbiguino, A. , M. Mabika et al., Human papillomavirus genotypes distribution among Gabonese women with normal cytology and cervical abnormalities, Infectious Agents Cancer, vol.11, issue.2, 2016.

B. Garcia-espinosa, M. P. Nieto-bona, S. Rueda, L. F. Silva-sanchez, M. C. Piernasmorales et al., Genotype distribution of cervical human papillomavirus DNA in women with cervical lesions in Bioko, Equatorial Guinea Diagn Pathol, vol.4, p.31, 2009.

J. S. Smith, A. Melendy, R. K. Rana, and J. M. Pimenta, Age-specific prevalence of infection with human papillomavirus in females: a global review, J Adolesc Health, vol.43, issue.4, 2008.

D. Pirek, P. Petignat, P. Vassilakos, J. Gourmaud, J. C. Pache et al., Human papillomavirus genotype distribution among Cameroonian women with invasive cervical cancer: a retrospective study, Sex Transm Infect, vol.91, issue.6, pp.440-444, 2015.

W. Qu, G. Jiang, Y. Cruz, C. J. Chang, G. Y. Ho et al., PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems, J Clin Microbiol, vol.35, issue.6, pp.1304-1314, 1997.

P. E. Gravitt, C. L. Peyton, T. Q. Alessi, C. M. Wheeler, F. Coutlee et al., Improved amplification of genital human papillomaviruses, J Clin Microbiol, vol.38, issue.1, pp.357-61, 2000.

G. Quiroga-garza, H. Zhou, D. R. Mody, M. R. Schwartz, and Y. Ge, Unexpected high prevalence of HPV 90 infection in an underserved population: is it really a low-risk genotype?, Arch Pathol Lab Med, vol.137, issue.11, pp.1569-73, 2013.

L. Fu, K. Van-doorslaer, Z. Chen, T. Ristriani, M. Masson et al., Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity, PloS One, vol.5, issue.9, 2010.

E. L. Franco, L. L. Villa, P. Rahal, and A. Ruiz, Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection, J Natl Cancer Inst, vol.86, issue.20, pp.1558-1567, 1994.

L. L. Villa, L. Sichero, P. Rahal, O. Caballero, A. Ferenczy et al., Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia, J Gen Virol, vol.81, pp.2959-68, 2000.

L. M. Boumba, Z. Qmichou, M. Mouallif, M. Attaleb, M. E. Mzibri et al., Human papillomavirus genotypes distribution by cervical cytologic status among women attending the General Hospital of Loandjili, J Med Virol, 2015.

F. M. Buonaguro, M. L. Tornesello, I. Salatiello, P. Okong, L. Buonaguro et al., The uganda study on HPV variants and genital cancers, J Clinvirol, vol.19, issue.1-2, pp.31-41, 2000.

Z. Qmichou, M. Khyatti, M. Berraho, M. M. Ennaji, L. Benbacer et al., Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women, BMC Infect Dis, vol.13, p.378, 2013.

Z. Qmichou and M. ,

, El Mostafa El Fahime

M. Melloul and . Khair,

M. E. Mzibri;-meriem and . Khyatti, Mohammed Attaleb Molecular Characterization of HPV16 E6 and E7 Variants among Women with Cervical Cancer in Morocco, Br Microbiol Res J, vol.3, issue.4, pp.692-705, 2013.

J. P. Mosmann, M. S. Monetti, M. C. Frutos, A. X. Kiguen, R. F. Venezuela et al., Mutation detection of E6 and LCR genes from HPV 16 associated with carcinogenesis, Asian Pac J Cancer Prev, vol.16, issue.3, pp.1151-1158, 2015.

S. Pande, N. Jain, B. K. Prusty, S. Bhambhani, S. Gupta et al., Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India, J Clin Microbiol, vol.46, issue.3, pp.1060-1066, 2008.

S. Perez, A. Cid, A. Inarrea, M. Pato, M. J. Lamas et al., Prevalence of HPV 16 and HPV 18 lineages in Galicia, Spain. PloS One, vol.9, issue.8, p.104678, 2014.

H. U. Bernard, I. E. Calleja-macias, and S. T. Dunn, Genome variation of human papillomavirus types: phylogenetic and medical implications, Int J Cancer, vol.118, issue.5, pp.1071-1077, 2006.